Introduction {#sec1-1}
============

Hypertension (HTN) is one of the most important risk factors that can lead to cardiovascular diseases (CVD) and is thus regarded as a serious public health problem. The prevalence of HTN has been increasing in most areas worldwide, especially in developing countries ([@ref1]). Studies in Iran have also shown a high incidence of the condition ([@ref2]). A previous study from this area showed that almost one-third of the CVD events and 27% of mortalities ensued from HTN, indicating the highest attributable risks ([@ref3]). The presence of other risk factors such as insulin resistance, dyslipidemia, obesity, and metabolic syndrome increases the HTN's harmful impact on target organs and CVD risk ([@ref4]).

HTN is very complex, and both environmental and genetic factors are involved. Yet, it is linked to overweight and obesity in several ways ([@ref5]). Several epidemiological studies have revealed a strong relationship between obesity and HTN, but there is still controversy regarding the best obesity indicator for HTN and the most appropriate cut-off point to use ([@ref6]-[@ref9]).

Several indirect methods are able to precisely estimate obesity, such as the total amount of body fat, as well as its distribution ([@ref10]). While using computed tomography, dual-energy X-ray absorptiometry, and magnetic resonance imaging has a high sensitivity and specificity to diagnose obesity, using anthropometric indices such as body mass index (BMI), waist-to-hip ratio (WHtR), waist circumference (WC), the waist-to-hip ratio (WHpR), and the waist-to-height ratio (WHtR) are the simplest and the most cost-effective methods recommended in clinical practice and in epidemiological studies ([@ref10], [@ref11]). A relatively large body of data is available regarding cut-off values of obesity indicators to predict HTN among different populations ([@ref12]-[@ref14]). Nevertheless, the relationship between obesity indicators and cardiovascular risk factors and HTN in particular, to the best of our knowledge, has not been fully established in an Iranian population. We believe that ethnic and racial differences in our population might require different cut-off points and/or use of different anthropometric parameters to predict HTN.

There is however often a vigorous debate, particularly regarding at which values obesity indices are better predictors of HTN incidence. Therefore, this study was designed to compare different obesity indicators, as well as to determine their best cut-off points regarding the incidence of HTN in an Iranian population.

Methods {#sec1-2}
=======

Study population {#sec2-1}
----------------

The Isfahan Cohort Study (ICS) is a population-based, ongoing longitudinal study of adults aged 35 years old or older, living in urban and rural areas of three counties in central Iran: Isfahan, Najafabad, and Arak ([@ref15]). The population was divided into urban and rural areas according to a general census conducted in 2008. These three cities were selected due to their consistent populations and a smaller number of migrants compared to the capital and other Iranian cities. Nearly 5%--10% of this population were included in the study. Moreover, Isfahan is the third largest city in Iran with 1.986.542 individuals living in this city and its surrounding villages. In Arak and Najafabad, the population was 555.975 and 282.430 in 2006, respectively ([@ref16]). The participants were recruited from January 2 to September 28, 2001. Participants were selected by multistage random sampling and were recruited to reflect the age, sex, and urban/rural distribution of the community ([@ref17]). Patient subgroups \<35 years are at times referred to as very young and less likely to suffer from CVD, and hence we considered the cut-off point of 35 years of age to include subjects who are more prone to CVD ([@ref18]). The Ethics Committee of the Isfahan Cardiovascular Research Center approved the study.

Follow-up surveys {#sec2-2}
-----------------

After the baseline survey in 2001, the follow-up of the participants was carried out every 2 years. Telephone interviews were carried out in 2003 and in 2005--2006. In 2007, full structured interviews and physical and biochemical measurements were repeated in the same way as for the baseline survey. A fifth telephone interview follow-up was finished in 2011. The patients or their close family members were asked about the patients' health status using a questionnaire with a specific focus on cardiovascular and cerebrovascular events and experiencing any of the following five neurological symptoms (hemiparesis, dysarthria, facial asymmetry, imbalance, and transient monoocular blindness). If a patient was hospitalized due to a cardiovascular disease, records of the time in hospital were found and summarized by experienced personnel and were reviewed by cardiac and neurologic panel. If a patient died during the follow-up, the cause of death was asked from family members. The verbal autopsy used a predefined questionnaire, including a medical history and signs and symptoms before death. Expert nurses conducted additional secondary interviews for hospitalized cases where information was incomplete or inconsistent.

Assessments {#sec2-3}
-----------

After obtaining informed written consent, medical interview and physical examination were conducted. Measurements of blood pressure, anthropometric parameters as well as fasting blood tests were carried out following standard protocols and using calibrated instruments as previously described ([@ref19]).

For the biochemical analysis, 5 ml blood samples were drawn following 12 h of overnight fasting to measure the lipid profile and fasting blood sugar. Diabetes mellitus was defined as hyperglycemia at more than 126 mg/dL fasting blood sugar (or the use of diabetes medications). All testing of lipids and lipoprotein cholesterol concentrations were performed in the Isfahan Cardiovascular Research Center Laboratory previously described ([@ref20]).

In brief, using a mercury sphygmomanometer, blood pressure was measured in a sitting position and after a minimum resting period of 10 min. Phases I and V Korotkoff sounds were used to identify systolic blood pressure (SBP) and diastolic blood pressure (DBP), respectively; the SBP and DBP values were taken as the average of three different measurements, separated by 2 minutes from one another.

A range of anthropometric measurements was investigated. Weight was determined with individuals wearing light clothes and no shoes (Sega, Germany) to the nearest 0.1 kg on a calibrated beam scale. Height was also measured while individuals were barefoot using a wall-mounted stadiometer to the nearest 0.1 cm. WC was taken as the smallest circumference at or below the costal margin and the Hip circumference (HC) at the level of greater trochanter. BMI was computed as weight (kg) divided by height^2^ (m). Body adiposity index (BAI) was calculated using the equation suggested by Bergman et al. BAI=\[(hip circumference)/(height^1.5^)--18\] ([@ref21]). The WHpR and WHtR were calculated through dividing WC by HC and height, respectively.

To define central obesity based on WC, we used the recommendation of International Diabetes Federation for Middle Easterners as WC ≥94 cm in men and ≥80 cm in women ([@ref12]), the local recommendation for Iranian population to predict CVD events by ICS as WC ≥90 for men and ≥97 for women ([@ref22]), as well as the updated Adult Treatment Panel III guideline of the National Cholesterol Education Program as WC ≥102 cm in men and ≥88 cm in women ([@ref23]). According to the World Health Organization definition, a BMI≥25 means the individual is overweight, whereas a BMI≥30 indicates obesity ([@ref24]). Subjects who smoked daily were considered as current smokers.

In 2007 (the 7^th^ year of the follow-up), participants were invited for repeated laboratory measurements, physical examination, and an interview using the same protocol as the baseline survey. Laboratory measurement methods were similar in 2001 and 2007, but the autoanalyzer was different (Eppendorf, Hamburg, Germany, in 2001 and Hitachi 902, Japan, in 2007). Both instruments have been validated with an external standard laboratory center.

Statistical analysis {#sec2-4}
--------------------

Data entry was carried out using EPI info. Data were analyzed using the STATA software (Stata/IC 11.0, StataCorp LP, College Station, TX, USA). A test of normality for the distribution of variables was performed using the Kolmogorov--Smirnov test. Data were expressed as the mean±standard deviation. For all analyses, statistical significance was assessed at the level of 0.05 (two-tailed). No variable had more than 3% of missing values. Stochastic regression was used to impute missing values ([@ref25]). Due to skewness, the Mann-Whitney U test was employed to compare triglycerides and the triglycerides/HDL-C ratio between men and women. Remaining comparisons were made using Student's t-test and a chi-squared test.

The associations of adiposity indices as continuous variables with incident diabetes were separately assessed in crude and adjusted logistic regression models, and the models' fit were compared. The linearity of associations in the crude models was then evaluated. The discrimination power of indices was assessed using the receiver operating characteristic (ROC) analysis, and the best cut-off value for each index was derived. The association of adiposity indices as binary variables was subsequently assessed using the plan identical to continuous variables. Finally, the associations of central obesity indices with HTN were adjusted for BMI.

The deviance (a likelihood ratio statistic for comparing each model to the saturated model) and Akaike's information criteria (AIC, a statistical trade-off between the likelihood of a model against its complexity) were used as indicators of the goodness of fit of the model and prediction error. A lower value for both deviance and AIC indicates a better fit of the model. To test nonlinearity, all variables were modeled by restricted cubic splines with four knots at percentiles 5%, 35%, 65%, and 95% in a logistic regression model, separately in men and women. The value of the first knot was used as the reference for the estimation of odds ratios in each model ([@ref17]). The associations were adjusted for age, smoking, education, and a family history of diabetes, systolic blood pressure, and triglyceride/HDL-C ratio.

Results {#sec1-3}
=======

Among 6504 participants at the baseline evaluation in 2001, 6323 had no CVD history, of which 3283 participants were revisited in 2007, and laboratory measurements and physical examination were repeated. Among the population with repeated measurements, 833 (25.4%) participants with HTN at baseline were excluded, resulting in 2450 subjects included in this analysis. The average age of subjects was increased from 47.3±9.4 years in 2001 to 55.4±10.3 years in 2007. While obesity (BMI≥30 kg/m^2^) was more than twice higher in women, there was no significant difference in being overweight (BMI≥25 kg/m^2^) between men and women ([Table 1](#T1){ref-type="table"}). All anthropometric indices were correlated with each other, but the strongest correlations were seen for WC with WHtR (r=0.91, p\<0.001) and with HC (r=0.80, p\<0.001), having same patterns in both genders ([Supplementary Table 1](#T7){ref-type="table"}).

###### 

Characteristics of study participants

                                                                       Men n=1242     Women n=1208   Total n=2450   *P*-value
  -------------------------------------------------------------------- -------------- -------------- -------------- -----------
  Age (year)                                                           47.9±9.7       46.7±9.1       47.3±9.4       0.001
  Body mass index                                                      25.4±3.8       27.7±4.5       26.6±4.3       \<0.001
   Obesity (BMI≥30 kg/m^2^)                                            149 (12.0%)    363 (30.0%)    512 (20.9%)    \<0.001
   Overweight (BMI≥25 kg/m^2^)                                         495 (39.9%)    517 (42.8%)    1012 (41.3%)   0.139
  Body adiposity index                                                 27.3±4.3       35.4±5.6       31.3±6.4       \<0.001
  Waist circumference (cm)                                             91.8±10.9      95.7±12.5      93.7±11.9      \<0.001
   Central obesity (\>90/97 cm)[\*](#t1f1){ref-type="table-fn"}        728 (58.6%)    583 (48.3%)    1311 (53.5%)   \<0.001
   Central obesity (\>94/80 cm)[\*](#t1f1){ref-type="table-fn"}        564 (45.4%)    1080 (89.4%)   1644 (67.1%)   \<0.001
  Waist-to-hip ratio                                                   0.92±0.06      0.92±0.08      0.92±0.07      0.608
  Central obesity (\>0.85/0.90 cm)[\*\*](#t1f2){ref-type="table-fn"}   1063 (85.6%)   763 (63.2%)    1826 (74.5%)   \<0.001
  Waist-to-height ratio                                                0.54±0.06      0.61±0.08      0.58±.08       \<0.001
   Central obesity (\>0.5)                                             905 (72.9%)    1095 (90.6%)   2000 (81.6%)   \<0.001
  Triglycerides (mg/dL)                                                169.0±104.4    155.0±93.0     161.9±99.3     \<0.001
   Hypertriglyceridemia^[†](#t1f3){ref-type="table-fn"}^               741 (59.7%)    635 (52.6%)    1376 (56.2%)   \<0.001
  LDL cholesterol (mg/dL)                                              122.6±42.9     130.6±41.4     126.5±42.3     \<0.001
   High LDL cholesterol^[††](#t1f4){ref-type="table-fn"}^              550 (44.3%)    608 (50.3%)    1158 (47.3%)   0.003
  HDL cholesterol (mg/dL)                                              45.2±10.2      48.1±10.1      46.6±10.3      \<0.001
   Low HDL cholesterol^[‡](#t1f5){ref-type="table-fn"}^                438 (35.3%)    718 (59.4%)    1156 (47.2%)   \<0.001
  Triglycerides/HDL-C ratio                                            3.8±2.7        3.3±2.2        3.5±2.5        \<0.001
  Fasting plasma glucose (mg/dL)                                       85.5±28.6      86.8±29.6      86.1±29.1      0.243
  Diabetes^[‡‡](#t1f6){ref-type="table-fn"}^                           74 (6.0%)      105 (8.7%)     179 (7.3%)     0.009
  Family history of hypertension                                       221 (17.8%)    246 (20.4%)    467 (19.1%)    0.105
  Systolic blood pressure (mm Hg)                                      112.4±11.7     111.7±11.7     112.1±11.7     0.105
  Diastolic blood pressure (mm Hg)                                     73.9±7.8       73.5±7.9       73.7±7.9       0.140
  Ever smoking                                                         534 (43.0%)    37 (3.1%)      571 (23.3%)    \<0.001

The numerical values are presented as mean±standard deviation and compared using Student's t-test, except for items indicated by § where the Mann--Whitney U test was employed. Categorical data are shown as n (%) and are tested by chi-square.

Waist circumference ≥97 cm for women and ≥90 cm for men based on a previous ICS recommendation and ≥80 cm for women and ≥94 cm for men based on an International Diabetes Federation recommendation for Middle East.

Waist-to-hip ratio ≥0.85 for women and ≥0.90 cm for men (World Health Organization recommendation)

Triglycerides ≥150 mg/dL or on anti-lipid agents

LDL-C ≥130 mg/dL or on anti-lipid agents

HDL-C \<40 mg/dL for men \<50 mg/dL for women or on anti-lipid agents

Hyperglycemia at more than 126 mg/dL fasting blood sugar or use of diabetes medications

HDL - high-density lipoprotein; LDL - low-density lipoprotein

###### 

Pairwise correlation between anthropometric indices

               BMI          WC           WHpR         WHtR         HC        Height
  ------------ ------------ ------------ ------------ ------------ --------- --------
  **Men**                                                                    
  BMI          1                                                             
  WC           r=0.70       1                                                
  *P*\<0.001                                                                 
  WHpR         r=0.43       r=0.64       1                                   
  *P*\<0.001   *P*\<0.001                                                    
  WHtR         r=0.73       r=0.94       r=0.65       1                      
  *P*\<0.001   *P*\<0.001   *P*\<0.001                                       
  HC           r=0.59       r=0.82       r=0.09       r=0.73       1         
  *P*\<0.001   *P*\<0.001   *P*\<0.001   *P*\<0.001                          
  Height       r=-0.15      r=0.13       r=-0.08      r=-0.22      r=0.23    1
  *P*\<0.001   *P*\<0.001   *P*=0.012    *P*\<0.001   *P*\<0.001             
  **Women**                                                                  
  BMI          1                                                             
  WC           r=0.67       1                                                
  *P*\<0.001                                                                 
  WHpR         r=0.27       r=0.68       1                                   
  *P*\<0.001   *P*\<0.001                                                    
  WHtR         r=0.71       r=0.94       r=0.69       1                      
  *P*\<0.001   *P*\<0.001   *P*\<0.001                                       
  HC           r=0.68       r=0.77       r=0.05       r=0.68       1         
  *P*\<0.001   *P*\<0.001   *P*=0.023    *P*\<0.001                          
  Height       r=-0.14      r=0.11       r=-0.07      r=-0.22      r=0.22    1
  *P*\<0.001   *P*\<0.001   *P*=0.037    *P*\<0.001   *P*\<0.001             
  **Total**                                                                  
  BMI          1                                                             
  WC           r=0.70       1                                                
  *P*\<0.001                                                                 
  WHpR         r=0.33       r=0.65       1                                   
  *P*\<0.001   *P*\<0.001                                                    
  WHtR         r=0.74       r=0.91       r=0.61       1                      
  *P*\<0.001   *P*\<0.001   *P*\<0.001                                       
  HC           r=0.66       r=0.80       r=0.07       r=0.71       1         
  *P*\<0.001   *P*\<0.001   *P*\<0.001   *P*\<0.001                          
  Height       r=-0.28      r=-0.03      r=-0.06      r=-0.45      r=0.010   1
  *P*\<0.001   *P*=0.048    *P*\<0.001   *P*\<0.001   *P*=0.709              

BMI - body mass index; WC - waist circumference; HC - hip circumference; WHpR - waist-to-hip ratio; WHtR - waist-to-height ratio

After 7 years of follow-up, 542 (22.1%) new cases of HTN were found indicating cumulative incidence (95% CI) of 22.6% (20.3--24.9) in men and 21.6% (19.3--23.9) in women. In unadjusted models, WHtR was the strongest predictor of HTN with a 60% and 27% increase in the HTN risk for each SD increase in men and women, respectively ([Table 2](#T2){ref-type="table"}). It had the smallest deviance and AIC, indicating the best fit in the model. However, in adjusted models, the WHtR revealed an almost similar AIC and deviance to WC and BMI, which were similar and had the lowest AIC and deviance in men. In addition, WC had also the lowest AIC and deviance in women, with WHtR being again the closest index to WC.

###### 

Association of adiposity indices with incident hypertension for one standard deviation increase (n=2450)

  Cut-off points   Crude OR[\*](#t2f1){ref-type="table-fn"} (95% CI)   *P*-value   Deviance   AIC    Fully adjusted OR[\*\*](#t2f2){ref-type="table-fn"} (95% CI)   *P*-value   Deviance   AIC    C
  ---------------- --------------------------------------------------- ----------- ---------- ------ -------------------------------------------------------------- ----------- ---------- ------ --------
  **Men**                                                                                                                                                                                         
  WC               1.32 (1.13-1.55)                                    \<0.001     1315       1319   1.35 (1.13-1.60)                                               0.001       1190       1206   0.7222
  HC               1.41 (1.21-1.63)                                    \<0.001     1304       1311   1.28 (1.09-1.50)                                               0.003       1193       1209   0.7263
  Height           0.81 (0.69-0.97)                                    0.021       1323       1327   1.02 (0.85-1.22)                                               0.861       1202       1218   0.7167
  WHpR             1.41 (1.22-1.62)                                    \<0.001     1305       1309   1.20 (1.03-1.40)                                               0.020       1196       1212   0.7245
  WHtR             1.60 (1.36-1.89)                                    \<0.001     1295       1299   1.35 (1.13-1.62)                                               0.001       1191       1207   0.7260
  BMI              1.35 (1.17-1.57)                                    \<0.001     1311       1315   1.32 (1.12-1.56)                                               0.001       1190       1206   0.7282
  BAI              1.41 (1.16-1.71)                                    \<0.001     1315       1319   1.23 (1.00-1.51)                                               0.050       1198       1214   0.7204
  **Women**                                                                                                                                                                                       
  WC               1.14 (1.00-1.31)                                    0.053       1257       1261   1.20 (1.04-1.39)                                               0.011       1164       1180   0.6976
  HC               1.20 (1.05-1.37)                                    0.006       1253       1257   1.17 (1.01-1.35)                                               0.031       1166       1182   0.6926
  Height           0.88 (0.72-1.07)                                    0.216       1259       1263   1.08 (0.87-1.33)                                               0.477       1170       1186   0.6889
  WHpR             1.23 (1.08-1.39)                                    0.002       1251       1255   1.10 (0.96-1.26)                                               0.174       1168       1184   0.6885
  WHtR             1.27 (1.11-1.45)                                    \<0.001     1249       1252   1.18 (1.02-1.36)                                               0.023       1165       1181   0.6922
  BMI              1.14 (1.00-1.30)                                    0.042       1257       1261   1.13 (0.98-1.29)                                               0.091       1167       1183   0.6918
  BAI              1.18 (1.01-1.38)                                    0.034       1256       1260   1.14 (0.96-1.34)                                               0.125       1168       1184   0.6890

Per one standard deviation increase for each index. Because of strong correlations among these variables, each one was evaluated in a separate model.

Adjusted for age, smoking, education, and family history of hypertension, diabetes, triglyceride/HDL-C ratio

OR - odds ratio; CI - confidence interval; BMI - body mass index; HDL - high-density lipoprotein; WC - waist circumference; WHpR - waist-to-hip ratio; WHtR - waist-to-height ratio

In men, the adjusted risk of incident HTN for each unit increase in WC (1 cm), HC (1 cm), WHpR (0.01), WHtR (0.01), BMI (0.1 kg/m^2^), and BAI (0.1) was linearly increased as 2.3%, 2.5%, 2.3%, 3.5%, 0.8%, and 0.3%, respectively. In women, for each unit increase in WC (1 cm), HC (1 cm), and BMI (0.1 kg/m^2^), the adjusted risk of incident HTN was linearly increased as 1.4%, 1.7%, and 0.3%, respectively ([Supplementary Table 2](#T8){ref-type="table"}).

###### 

Association of continuous adiposity indices with incident hypertension

  Cut-points    Crude OR[\*](#t8f1){ref-type="table-fn"} (95% CI)   *P*-value   Deviance   AIC    Fully Adjusted OR[\*\*](#t8f2){ref-type="table-fn"} (95% CI)   *P*-value   Deviance   AIC
  ------------- --------------------------------------------------- ----------- ---------- ------ -------------------------------------------------------------- ----------- ---------- ------
  **Men**                                                                                                                                                                               
  WC (cm)       1.033 (1.011-1.046)                                 \<0.001     1303       1307   1.023 (1.009-1.038)                                            0.001       1191       1207
  HC (cm)       1.025 (1.008-1.042)                                 0.003       1319       1323   1.025 (1.007-1.043)                                            0.007       1194       1210
  Height (cm)   0.981 (0.963-1.000)                                 0.051       1324       1329   1.006 (0.985-1.027)                                            0.567       1201       1217
  WHpR×100      1.048 (1.027-1.069)                                 \<0.001     1307       1311   1.023 (1.001-1.046)                                            0.042       1198       1214
  WHtR×100      1.060 (1.038-1.083)                                 \<0.001     1297       1301   1.035 (1.012-1.060)                                            0.003       1193       1209
  BMI×10        1.008 (1.005-1.017)                                 \<0.001     1307       1311   1.008 (1.004-1.012)                                            \<0.001     1186       1202
  BAI×10        1.006 (1.003-1.010)                                 \<0.001     1312       1316   1.003 (1.000-1.007)                                            0.043       1197       1213
  **Women**                                                                                                                                                                             
  WC (cm)       1.016 (1.005-1.028)                                 \<0.001     1252       1256   1.014 (1.002-1.027)                                            0.026       1165       1181
  HC (cm)       1.011 (0.997-1.025)                                 0.129       1258       1262   1.017 (1.001-1.032)                                            0.031       1166       1182
  Height (cm)   0.990 (0.971-1.010)                                 0.329       1260       1264   1.010 (0.989-1.032)                                            0.343       1169       1185
  WHpR×100      1.027 (1.008-1.045)                                 0.004       1253       1257   1.010 (0.990-1.029)                                            0.320       1169       1185
  WHtR×100      1.028 (1.010-1.045)                                 0.002       1251       1255   1.017 (0.999-1.036)                                            0.060       1167       1183
  BMI×10        1.004 (1.001-1.007)                                 0.017       1255       1259   1.003 (1.000-1.007)                                            0.037       1166       1182
  BAI×10        1.002 (1.000-1.005)                                 0.039       1256       1260   1.002 (0.999-1.004)                                            0.159       1168       1184

Per unit of measurement for each index. Each variable was evaluated in a separate model.

Adjusted for age, smoking, education, and family history of hypertension, diabetes, triglyceride/HDL-C ratio

OR - odds ratio; CI - confidence interval; BMI - body mass index; WC - waist circumference; HC - hip circumference; WHpR - waist-to-hip ratio; WHtR - waist-to-height ratio

Considering logistic models including restricted cubic splines, the null hypothesis indicating that coefficient of the 2^nd^ and 3^rd^ splines equaled zero was not rejected (p\>0.05) for all interested factors in men and women. Accordingly, all associations between continuous indicators were found to be linear.

[Table 3](#T3){ref-type="table"} represents what central obesity adds to BMI for incident HTN prediction. In men, except for HC, all central adiposity indices were associated with HTN independent of BMI; moreover, BMI lost its statistically significant association when WC or WHtR were introduced to the models. On the other hand, in women, WHpR and WHtR were independently associated with HTN; however, BMI did not show any significant association with each of the central obesity indices included in the model.

###### 

Body mass index adjusted associations of one standard deviation increase in central obesity indices with incident hypertension

                          Central obesity indices OR (95% CI)   *P*-value   Body mass index OR (95% CI)   *P*-value   Deviance   AIC    C
  ----------------------- ------------------------------------- ----------- ----------------------------- ----------- ---------- ------ -------
  **Men**                                                                                                                               
  Body mass index         \-                                    \-          1.35 (1.17-1.57)              \<0.001     1311       1315   0.576
  Waist circumference     1.28 (1.06-1.55)                      0.011       1.16 (0.96-1.40)              0.133       1310       1304   0.593
  Hip circumference       1.15 (0.96-1.39)                      0.134       1.26 (1.05-1.50)              0.010       1309       1315   0.586
  Waist-to-hip ratio      1.31 (1.13-1.53)                      \<0.001     1.22 (1.04-1.43)              0.014       1299       1305   0.600
  Waist-to-height ratio   1.55 (1.24-1.92)                      \<0.001     1.05 (0.86-1.27)              0.637       1295       1301   0.606
  **Women**                                                                                                                             
  Body mass index         \-                                    \-          1.14 (1.00-1.30)              0.042       1257       1261   0.538
  Waist circumference     1.17 (0.99- 1.39)                     0.058       1.03 (0.87-1.22)              0.686       1253       1259   0.557
  Hip circumference       1.08 (0.90-1.28)                      0.400       1.09 (0.92-1.29)              0.298       1256       1262   0.543
  Waist-to-hip ratio      1.20 (1.05-1.37)                      0.007       1.09 (0.95-1.25)              0.211       1249       1255   0.569
  Waist-to-height ratio   1.30 (1.09-1.56)                      0.004       0.96 (0.81-1.14)              0.627       1248       1254   0.570

OR - odds ratio; CI - confidence interval

Considering subjects with BMI 18.5--25 kg/m^2^ as a reference group, the risk of developing HTN significantly increased in overweight men \[1.73 (1.29--2), p=0.001\] but not in overweight women \[1.33 (0.93--1.89), p=0.114\]. Obesity was related to an increased risk of incident HTN in men \[2.21 (1.48--3.32), p\<0.001\] and women \[1.59 (1.10--2.31), p=0.014\]. On the other hand, WC, WHpR, and WHtR had significant associations with the incidence of HTN in participants who had normal weight, but not in overweight and obese subjects ([Table 4](#T4){ref-type="table"}). WHtR was marginally associated with an increased risk of HTN in obese men.

###### 

Association of central obesity indices with incident hypertension in normal weight, overweight, and obese subjects

                          Normal OR (95% CI)   *P*-value   Overweight OR (95% CI)   *P*-value   Obese OR (95% CI)   *P*-value
  ----------------------- -------------------- ----------- ------------------------ ----------- ------------------- -----------
  **Men**                                                                                                           
  **n**                   598                              495                                  149                 
  Waist circumference     1.58 (1.18-2.11)     0.002       1.05 (0.79-1.39)         0.738       1.10 (0.72-1.66)    0.664
  Hip circumference       1.30 (0.97-1.73)     0.075       1.04 (0.79-1.38)         0.743       0.98 (0.63-1.53)    0.935
  Waist-to-hip ratio      1.32 (1.06-1.65)     0.014       1.21 (0.95-1.55)         0.117       1.48 (1.00-2.20)    0.050
  Waist-to-height ratio   1.90 (1.37-2.63)     \<0.001     1.12 (0.81-1.55)         0.473       1.57 (0.92-2.69)    0.095
  **Women**                                                                                                         
  **n**                   328                              517                                  363                 
  Waist circumference     1.81 (1.28-2.56)     0.001       1.04 (0.80-1.35)         0.749       0.93 (0.71-1.22)    0.608
  Hip circumference       1.10 (0.79-1.52)     0.575       1.05 (0.80-1.38)         0.727       1.01 (0.76-1.35)    0.929
  Waist-to-hip ratio      1.75 (1.31-2.33)     \<0.001     1.05 (0.86-1.29)         0.613       1.06 (0.85-1.32)    0.615
  Waist-to-height ratio   1.94 (1.32-2.83)     0.001       1.23 (0.94-1.61)         0.133       0.98 (0.75-1.30)    0.914

Normal, BMI 18.5--24.9 kg/m^2^ ; Overweight, BMI 25--29.9 kg/m^2^ ; Obese, BMI ≥30 kg/m^2^ The associations were calculated for one standard deviation increase. OR - odds ratio; BMI - Body mass index; CI - confidence interval

Height significantly decreased the HTN risk in crude models in men, but not in adjusted models and in women. No statistically significant interaction was found between height and other factors (data not shown). HC showed no statistically significant association when it was adjusted for age and WC in men (p=0.918) and women (p=0.490). The same pattern was seen when more adjusted factors were included.

A ROC curve analysis showed the highest discrimination power \[area under the curve (AUC)\] in WHtR for men and women closely followed by WC ([Table 5](#T5){ref-type="table"}). For each anthropometric index, the optimal cut-off point is presented maximizing Youden's index for incident HTN and its corresponding sensitivity and specificity in men and women. The highest positive likelihood ratio was observed in the indices with highest AUC.

###### 

Best Cut-off values of adiposity indices maximizing sensitivity plus specificity using receiver operating characteristic analysis for detecting incident hypertension

              Best cut-off points   Sensitivity   Specificity   Youden index[\*](#t5f1){ref-type="table-fn"}   LR+    LR-    AUC (95% CI)
  ----------- --------------------- ------------- ------------- ---------------------------------------------- ------ ------ ------------------------------------------------------
  **Men**                                                                                                                    
  WC          93 cm                 0.630         0.552         0.181                                          1.40   0.67   0.602 (0.565-0.639)
  WHpR        0.92                  0.587         0.564         0.151                                          1.35   0.73   0.597 (0.560-0.634)^[†](#t5f2){ref-type="table-fn"}^
  WHtR        0.45                  0.644         0.538         0.182                                          1.39   0.66   0.612 (0.575-0.648)^[†](#t5f2){ref-type="table-fn"}^
  BMI         24.9                  0.655         0.509         0.164                                          1.33   0.68   0.591 (0.553-0.628)^[†](#t5f2){ref-type="table-fn"}^
  BAI         26.2                  0.737         0.415         0.145                                          1.25   0.65   0.585 (0.549-0.622)^[†](#t5f2){ref-type="table-fn"}^
  **Women**                                                                                                                  
  WC          98 cm                 0.540         0.572         0.112                                          1.26   0.80   0.560 (0.521-0.599)
  WHpR        0.92                  0.663         0.466         0.119                                          1.22   0.74   0.561 (0.522-0.600)
  WHtR        0.59                  0.713         0.391         0.103                                          1.70   0.73   0.563 (0.525-0.602)
  BMI         29.0                  0.448         0.637         0.085                                          1.23   0.86   0.549 (0.510-0.588)
  BAI         35.3                  0.575         0.519         0.093                                          1.19   0.82   0.542 (0.502-0.580)

sensitivity+specificity-1

AUC for WHtR \[0.032 (0.026 (0.002--0.050), *P*=0.032, (0.036 (0.064--0.007), *P*=0.013, 0.022 (0.008--0.036), *P*=0.002\] was significantly higher than BAI and WHpR and WC respectively; no other significant differences were observed in men.

No significant differences were observed in women.

BMI - Body mass index; WC - waist circumference; WHpR - waist-to-hip ratio; WHtR - waist-to-height ratio;

LR+ - positive likelihood ratio; LR- - negative likelihood ratio; AUC - area under the curve; CI - confidence interval

[Table 6](#T6){ref-type="table"} shows the association between central and overall obesity with incident HTN considering different definitions, including those derived from findings in [Table 5](#T5){ref-type="table"}. In the crude model, a WC≥93 cm was the best predictor in men followed by a BMI≥24.9 kg/m^2^. However, when the association was adjusted for other risk factors, a BMI≥24.9 kg/m^2^ was considerably better than other indices for men, resulting in 72.8% right discrimination in the adjusted model. In women, WC≥98 cm was the best in both the crude and adjusted model with a 69.8% discrimination.

###### 

Best cut-off values of anthropometric indices maximizing univariate and multivariate model prediction efficacy for incident hypertension

                Best cut-off points   Crude OR (95% CI)   *P*-value   Deviance   AIC    Adjusted OR (95% CI)   *P*-value   Deviance   AIC    AUC^[†](#t6f1){ref-type="table-fn"}^
  ------------- --------------------- ------------------- ----------- ---------- ------ ---------------------- ----------- ---------- ------ --------------------------------------
  **Men**                                                                                                                                    
  WC            102                   1.66 (1.21-2.28)    0.002       1319       1323   1.42 (1.01-2.00)       0.045       1198       1214   0.721
  ATPIII        94                    2.08 (1.59-2.73)    \<0.001     1299       1303   1.71 (1.27-2.30)       0.001       1189       1205   0.725
  IDF           90                    1.82 (1.37-2.42)    \<0.001     1310       1314   1.47 (1.07-2.01)       0.016       1196       1212   0.720
  ICS for CVD   93 cm                 2.09 (1.59-2.75)    \<0.001     1299       1303   1.70 (1.26-2.29)       0.001       1190       1206   0.723
  WHpR          0.90                  1.86 (1.37-2.52)    \<0.001     1311       1315   1.37 (0.99-1.91)       0.059       1198       1214   0.721
  WHO           0.92                  1.65 (1.26-2.16)    \<0.001     1315       1319   1.20 (0.89-1.62)       0.224       1200       1216   0.719
  WHtR          0.45                  2.17 (1.17-4.04)    0.014       1321       1325   1.77 (0.92-3.41)       0.088       1198       1214   0.719
  BMI           24.9                  1.96 (1.48-2.58)    \<0.001     1305       1309   1.91 (1.40-2.62)       \<0.001     1185       1201   0.728
  BAI           26.2                  1.88 (1.40-2.52)    \<0.001     1309       1313   1.50 (1.10-2.05)       0.011       1195       1211   0.721
  **Women**                                                                                                                                  
  WC            88 cm                 1.50 (1.06- 2.12)   0.022       1255       1259   1.40 (0.97-2.02)       0.073       1167       1183   0.692
  ATPIII        80 cm                 2.22 (1.27-3.88)    0.005       1251       1255   1.85 (1.03-3.30)       0.038       1166       1182   0.692
  IDF           97 cm                 1.45 (1.10-1.91)    0.008       1254       1258   1.33 (0.99-1.78)       0.055       1167       1183   0.691
  ICS for CVD   98 cm                 1.69 (1.28-2.23)    \<0.001     1247       1251   1.57 (1.17-2.10)       0.003       1161       1177   0.698
  WHpR          0.85                  1.26 (0.84-1.87)    0.264       1259       1264   1.07 (0.70-1.63)       0.767       1170       1186   0.688
  WHO           0.92                  1.65 (1.24-2.20)    0.001       1249       1253   1.36 (1.00-1.84)       0.046       1166       1182   0.690
  WHtR          0.59                  1.59 (1.18-2.14)    0.002       1251       1255   1.39 (1.01-1.91)       0.040       1166       1182   0.691
  BMI           29                    1.40 (1.06-1.85)    0.017       1255       1259   1.43 (1.06-1.93)       0.018       1164       1181   0.691
  BAI           35.3                  1.34 (1.02-1.77)    0.034       1256       1260   1.23 (0.92-1.64)       0.162       1168       1184   0.688

Adjusted for age, smoking, education, and family history of hypertension, diabetes, triglyceride/HDL-C ratio

Area under the curve for multivariate logistic regression models indicating the ability of model for right discrimination

OR - odds ratio; CI - confidence interval; BMI - body mass index; WC - waist circumference; WHpR - waist-to-hip ratio, WHtR - waist-to-height ratio; DM - diabetes mellitus

Discussion {#sec1-4}
==========

In this large cohort study that included Iranian adults, we found that BMI in men and WC in both men and women were the best continuous predictors of incident HTN. In addition, a BMI≥24.9 kg/m^2^ in men and WC≥98 cm in women were the best fitted binary indices in multivariate adjusted models, while central obesity was independently associated with an increased risk in participants whose weight was normal.

Although many cross-sectional studies have been conducted to indicate the association between anthropometric indicators and HTN, to the best of our knowledge, this is the first large-scale cohort study in an Iranian population that compares the obesity indices with regard to the HTN risk. It is well documented that ethnic and racial differences affect determining the optimal anthropometric indicators to predict cardiovascular risk factors ([@ref26]). In this regard, a study by Tuan et al. ([@ref27]) demonstrated no superiority in obesity indices to predict the HTN risk among Chinese adults; however, published reports from various parts of the world reported dissimilar indicators as superior indices ([@ref28]-[@ref36]).

Adiposity indices could be treated as binary indicators to determine those at risk or as original continues values. These two approaches can lead to different best indices. While the first approach is inevitably needed to identify those needing clinical interventions, the latter is important for assessing the effect for incremental increases. However, in our study, the two approaches resulted in reporting similar optimal indices.

Some studies believe that WC is a preferable indicator to predict HTN ([@ref28]). Gus et al. ([@ref29]) also showed the risk for HTN might be better identified by obesity defined by a higher WC than a higher BMI in Brazilian population. Moreover, some investigators have proposed that WC is a superior indicator because it only requires one measurement and correlates well with visceral adiposity among South East Asians ([@ref30], [@ref31]). Ardern et al. ([@ref32]) revealed that WC is a better predictor for CVD risks than BMI in American (White, Black, and Hispanic) and Canadian participants of different age, body composition, lifestyles, and socioeconomic characteristics. Several mechanisms were suggested to explain this finding. First of all, unlike BMI, WC in crude analysis is an indicator that shows the distribution of body fat in the abdominal region, which is more related to cardiovascular risks than body weight ([@ref33]). However, BMI as an indicator of general obesity has been shown in some studies to be as strong as central-obesity indices such as WC in predicting cardiovascular risk factors ([@ref34], [@ref35]). In addition, a study by Li et al. ([@ref36]) showed that the combination of BMI and WC could increase the predictive efficacy of the HTN incidence. Similarly, our findings showed that BMI and WC are the best continuous predictors in men and women, respectively.

Studies have shown that the percentage of total body fat is higher in shorter individuals than in taller individuals with the same BMI ([@ref37]); thus, considering the power of WC, a simple measure of central obesity for HTN prediction that does not account for differences in height, may not be a valid measure for predicting HTN ([@ref37]). Diabetes and HTN have also been shown to be more prevalent in short-statute subjects compared with taller subjects, even after adjusting for confounders ([@ref27], [@ref37]). A recent longitudinal study showed that the predictive power of WC for incident HTN was improved when WC was corrected with height or HC ([@ref28], [@ref37]). However, in our population, central obesity was more prevalent than overall obesity measured by BMI. Therefore, these further support the use of both BMI and WC as the two best indices for the prediction of incident HTN in both genders.

Azimi-Nezhad et al. ([@ref38]) in their cross-sectional study on another Iranian population reported that WHtR was the strongest predictor for HTN, and for practical reasons, the values of 0.5 for men and 0.6 for women may be the most practical measures to be used. This is comparable to our cut-off points for WHtR being 0.45 for men and 0.59 for women. However, considering different definitions of anthropometric cut-off points in our study, BMI and WC seemed to have the best HTN predictor cut-off points for men and women, respectively. In addition, we found that the cut-off points were all higher in women than in men. As previously reported, men in this population showed a higher incidence of CVD ([@ref39]).

As in line with previous reports from the same studied population determining the best anthropometry indices for predicting diabetes mellitus and CVD ([@ref17], [@ref39]), our results suggest that separate analyses for males and females may be worthwhile. Significant heterogeneity between the sexes was found for BMI when discriminating the HTN risk and the rankings of the overweight and obesity indices as best cardiovascular risk discriminators varied between males and females.

Study limitation {#sec2-5}
----------------

This study had several strengths, including its large sample size from a multicenter setting with a wide-area coverage from urban and rural regions, and to directly measure anthropometric indices. However, the fact that our population was Iranian limits the generalizability of our findings beyond the Middle East region.

Conclusion {#sec1-5}
==========

In conclusion, both WC and BMI, and BMI on its own, were the best binary and continuous indicators for men, respectively. In addition, WC found to be the best predictor of HTN as both the continuous and binary factor for women. Furthermore, the best cut-off points for adiposity indices were BMI for men and WC for women.
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